Grail has filed for Food and Drug Administration approval of its multi-cancer early detection test, the company said Thursday ...

The U.S. Food and Drug Administration (FDA) has approved a drug to control seizures in dogs with idiopathic epilepsy, a type ...

Executive Vice President of Commercial Marion McCourt highlighted "EYLEA HD net sales reached $506 million, representing 18% sequential growth" and noted "new real-world market data shows that on ...

Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in patients with glaucoma and NAION.

Dr. Myron Czuczman highlighted the significance of the recent U.S. Food and Drug Administration (FDA) approval of Lymphir ...

The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...

Established drugs were repurposed, “me-too” drugs were approved, and even the few new biological approaches lacked clinical ...

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...

A new drug application (NDA) has been submitted to the FDA seeking approval of lirafugratinib (RLY-4008), a selective FGFR2 ...

FDA approves KBroVet chewable tablets for managing canine idiopathic epilepsy.

The FDA has approved the first dual-agent eye drop to treat presbyopia, a condition that causes gradual loss of near vision in adults.

The West Virginia House of Delegates and Mississippi House of Representatives have both approved bills to support research in ...